Podcast: Key Business Considerations for Growing BioPharm Product Pipeline
Feb 10, 2012
By BioPharm International Editors
In this first intervew with BioPharm International, Tarja Mottram, CEO of Action for Results, discusses some of the deeper business considerations for companies planning to grow with a pipeline or portfolio. Posted Feb. 2012.
Testing product and process intermediates alone is helpful, but does not provide a complete solution to viral safety. This article proposes integrated solutions for systemic and proactive viral risk mitigation.